Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study

Cited by (455)

Items 301–400 of 455

1. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10 years after first-ever ischemic stroke
   Maria A. Baturova, Arne G. Lindgren, Jonas Carlson, Yu. V. Shubik, Sandra Olsson, Pyotr G. Platonov · 2017 · International Journal of Cardiology
2. Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor ( CHA 2 DS 2 VAS c 1 or 2): A treatment dilemma
   Gentian Denas, Giacomo Zoppellaro, Seena Padayattil Jose, Emilia Antonucci, Francesco Marongiu, Daniela Poli, Sophie Testa, Armando Tripodi, Gualtiero Palareti, Vittorio Pengo · 2017 · Cardiovascular Therapeutics
3. Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup
   Thomas F. Deering · 2017 · Journal of Atrial Fibrillation
4. Oral anticoagulation in patients with active cancer and atrial fibrillation: current challenges
   Marc Sorigué · 2020 · Polskie Archiwum Medycyny Wewnętrznej
5. Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
   Duncan Wilson, Gareth Ambler, Clare Shakeshaft, Gargi Banerjee, Andreas Charidimou, David Julian Seiffge, Mark J White, Hannah Cohen, Tarek Ahmed Yousry, Al-Shahi Salman Rustam et al. · 2019 · BMJ Open
6. History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry.
   Rungroj Krittayaphong, Arjbordin Winijkul, Wattana Wongtheptien, Chaiyasith Wongvipaporn, Treechada Wisaratapong, Rapeephon Kunjara-Na-Ayudhya, Smonporn Boonyaratvej, Pontawee Kaewcomdee, Ahthit Yindeengam · 2020 · PubMed Central
7. Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case
   Guowei Li, Lehana Thabane, Thomas Delate, Daniel M. Witt, Mitchell Levine, Ji Cheng, Anne Marie Holbrook · 2016 · PLoS ONE
8. Implantierbarer Loop-Rekorder BioMonitor 2 (Fa. Biotronik)
   Thorsten Lewalter, Clemens Jilek · 2016 · Herzschrittmachertherapie + Elektrophysiologie
9. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation
   Faris Al‐Khalili, Lina Benson, Leif Friberg · 2016 · EP Europace
10. Changes in stroke risk by freedom-from-stroke time in simulated populations with atrial fibrillation: Freedom-from-event effect when event itself is a risk factor
    Tomoki Nakamizo, Masahiro Yamamoto, Ken Johkura · 2018 · PLoS ONE
11. Apixaban in Comparison to Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies
    Muhammad Umer Siddiqui, David A. Scalzitti, Zunaira Naeem · 2019 · Cardiology Research and Practice
12. Non-vitamin K antagonist oral anticoagulant use at doses inappropriately lower than recommended in outpatient older adults: a real-life data
    Tuğba Erdoğan, Onur Erdoğan, Savaş Öztürk, Meryem Merve Ören, Mehmet Akif Karan, Gülistan Bahat · 2021 · European Geriatric Medicine
13. Reducing bleeding risk in patients on oral anticoagulation therapy
    Eva Soler‐Espejo, María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Vanessa Roldán, Francisco R. Marín · 2023 · Expert Review of Cardiovascular Therapy
14. Antithrombotic Management and Type of Stent in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
    Juan M. Ruiz-Nodar, Francisco R. Marín, Gregory Y.H. Lip · 2012 · Revista Española de Cardiología (English Edition)
15. Watchman Device: Left Atrial Appendage Closure For Stroke Prophylaxis In Atrial Fibrillation.
    Manoj Obeyesekere · 2014 · PubMed Central
16. Medical scores in clinical practice. Part II. Thromboembolism
    Farid Ismagilievich Belyalov · 2017 · Clinical Medicine (Russian Journal)
17. Left Atrial Appendage Closure Is Preferred to Chronic Warfarin Therapy
    Moustapha Atoui, Sampath Gunda, Dhanunjaya Lakkireddy · 2015 · Cardiac Electrophysiology Clinics
18. Oral anticoagulation in chronic kidney disease: A huge challenge
    Francisco R. Marín, Vanessa Roldán · 2012 · Thrombosis and Haemostasis
19. Warfarin therapy for atrial fibrillation in haemodialysis patients: mind the (evidence) gap
    Karolina Elisabeth Szummer, Juan Jesús Carrero · 2015 · Nephrology Dialysis Transplantation
20. Stürze und eine Demenz sind keine Kontraindikation für eine orale Antikoagulation bei älteren Patienten mit Vorhofflimmern
    Markus Gosch, Bernhard Iglseder, Hans Jürgen Heppner · 2016 · Zeitschrift für Gerontologie und Geriatrie
21. An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus
    Vera N. Larina, Olga Sh. Oynotkinova, A. P. Majorova, G. A. Egiazarian, Tatiana Yu. Demidova · 2021 · Rational Pharmacotherapy in Cardiology
22. Characteristics of warfarin under-prescription in older adults with atrial fibrillation
    Sana Rashid, Maciej Tysarowski, Jorge Naranjo, Atharva Dhole, Luka Petrovic, Emad F. Aziz · 2021 · IJC Heart & Vasculature
23. Integrating Complex Selection Rules Into the Latent Overlapping Group Lasso for the Construction of Coherent Prediction Models
    Guanbo Wang, Sylvie Perreault, Robert William Platt, Rui Wang, Marc Dorais, Mireille E. Schnitzer · 2025 · Statistics in Medicine
24. Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern
    Karl Georg Häusler, Matthias Endres, Ulf Landmesser · 2018 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
25. Uso amplio de anticoagulantes de acción directa en pacientes ancianos con fibrilación auricular: datos del registro REFLEJA
    Javier Torres Llergo, María Rosa Fernández Olmo, Magdalena Carrillo Bailén, Miguel Puentes Chiachío · 2020 · Revista Española de Cardiología
26. The atrial fibrillation epidemic: a validated diagnosis, or not?
    J B Olesen, Gregory Y.H. Lip, Laurent Fauchier · 2014 · EP Europace
27. Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?
    Yee Cheng Lau, Gregory Y.H. Lip · 2013 · EP Europace
28. Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement
    Kumbhani, Dharam J., Armbruster, Anastasia L., Cheng, Richard K., Chrispin, Jonathan, Fischer, Urs, Holbrook, Anne Marie, Joglar, Jose, Sevestre, Marie-Antoinette · 2026 · JACC
29. Anticoagulation in atrial fibrillation: the present and the future
    Marc Richard Dweck, Anoop S.V. Shah, Keith A.A. Fox · 2012 · JRSM Cardiovascular Disease
30. Embolic Stroke in Cardiomyopathy
    Akhil Narang, Roberto Miguel Lang · 2016 · Cardiology Clinics
31. Spectrophotometric Determination of Apixaban in Bulk Drug and Oral Dosage Formulation
    Deepshikha Sharma, Vikramsinh R. Chauhan, K. B. Vyas · 2019 · International Journal of Scientific Research in Science and Technology
32. Cost-effectiveness of direct oral anticoagulants in non-valvular atrial fibrillation
    Iñigo Gorostiza, Amaia Bilbao‐González, Javier Mar · 2025 · Gaceta Sanitaria
33. 2025 Thai guideline for the diagnosis and management of atrial fibrillation
    Tachapong Ngarmukos, Komsing Methavigul, Voravut Rungpradubvong, Sirin Apiyasawat, Wanwarang Wongcharoen, Satchana Pumprueg, Warangkna Boonyapisit, Arisara Suwanagool, Thoranis Chantrarat, Pattarapong Makarawate et al. · 2025 · Asian Biomedicine
34. Aspects of anticoagulant therapy in patients with atrial fibrillation in the light of updated guidelines of the European society of cardiology 2020: the position of dabigatran
    Кропачева Екатерина Станиславовна, Е. П. Панченко · 2020 · Aterotromboz = Atherothrombosis
35. Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score.
    Nathan E. K. Procter, Jocasta Ball, Tamila Heresztyn, Vivek Babu Nooney, Saifei Liu, Cher‐Rin Chong, Doan T M Ngo, Jeffrey Scott Isenberg, Yuliy Y. Chirkov, Simon Stewart et al. · 2015 · Europe PMC (PubMed Central)
36. Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry
    Akiko Suyama Chishaki, Naoko Kumagai, Naohiko Takahashi, Tetsunori Saikawa, Hiroshi Inoue, Ken Okumura, Hirotsugu Atarashi, Takeshi Yamashita, Hideki Origasa, Masayuki Sakurai et al. · 2015 · Thrombosis Research
37. Stroke prophylaxis in high-risk patients with atrial fibrillation: Rhythm vs. rate control strategy
    Alessandro Filippi, Massimo Zoni-Berisso, Giuliano Ermini, Maurizio Landolina, Ovidio Brignoli, G DʼAmbrosio, Gianluca Zingarini, Claudio Pedrinazzi · 2013 · European Journal of Internal Medicine
38. Antithrombotic therapy and bleeding risk in atrial fibrillation. Fewer unanswered questions
    Juan M. Ruiz-Nodar, Francisco R. Marín · 2013 · Thrombosis and Haemostasis
39. Prevención farmacológica de embolia por fibrilación auricular y sus escalas de riesgo de embolia y sangrado
    Enrique Melgarejo R. · 2016 · Revista Colombiana de Cardiología
40. Atrial fibrillation clinical decision aid for emergency medicine providers: An initiative to improve quality healthcare outcomes in adults with new-onset atrial fibrillation
    Christina Cardy, K. Michelle Ardisson, S. Brian Widmar · 2018 · Heart & Lung
41. Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)
    Amelia Filippelli, Simona Signoriello, Ciro Bancone, Graziamaria Corbi, Valentina Manzo, Severino Iesu, Cecilia Politi, Alberto Gigantino, Maria Teresa De Donato, Paolo Masiello et al. · 2019 · The Pharmacogenomics Journal
42. Pharmakologische Therapie kardiologischer Erkrankungen im Alter
    Markus Gosch · 2022 · Zeitschrift für Gerontologie und Geriatrie
43. Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
    Gordon K. T. Chu, Jaap Seelig, Emmy M. Trinks-Roerdink, Geert‐Jan Geersing, Frans Hendrik Rutten, Joris R. de Groot, Menno Volkert Huisman, Martin E W Hemels · 2020 · Netherlands Heart Journal
44. Amiodarone-Induced Immune Thrombocytopenia: A Rare Hematologic Side Effect of a Common Cardiac Drug
    Hardik Satish Chhatrala, Shreya Ghetiya, Michael Chahin, Lara Zuberi, Walter JR Quan · 2021 · Cureus
45. Efficiency of the Decision-Making Module in the Personalized Choice of an Anticoagulant
    Elena V. Gorbunova, S. P. Duvanovа, К.М. Филимонов, Sergey E. Mamchur, Сергей Анатольевич Макаров · 2021 · Kardiologiia
46. Optimising stroke prevention in patients with atrial fibrillation
    Deirdre A. Lane, A. Wolff, Eduard Shantsila, Gregory Y.H. Lip · 2015 · British Journal of General Practice
47. Clinical impact of perioperative atrial fibrillation on long-term recurrence of malignancy
    Satoshi Higuchi, Yusuke Kabeya, Kenichi Matsushita, Keisei Tachibana, Riken Kawachi, Hidefumi Takei, Ryota Tanaka, Yutaka Suzuki, Yorihisa Imanishi, Shigeki Shibata et al. · 2021 · Heart and Vessels
48. Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
    Fabio Angeli, Gianpaolo Reboldi, Giancarlo Agnelli, Giuseppe Ambrosio, Alessandro Capucci, Giovanni Carreras, Claudio Cavallini, Adriano Murrone, Gaetano Vaudo, Gianluca Zingarini et al. · 2023 · Clinics and Practice
49. Mechanical versus Biological Valve Prostheses for Infective Endocarditis Presenting with Stroke
    Amila Kahrovic, Philipp Angleitner, Harald Herkner, Paul Werner, Alexandra Andreeva, Thomas Poschner, Severin Laengle, Alfred A. Kocher, Günther Laufer, Martin Andreas · 2024 · Journal of Clinical Medicine
50. Visceral Embolic Events in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Incidence, Mortality, and Risk Prediction
    Yazan Jumah Alalwani, Waleed A. Alharthi, Hadeel Khalid Bin Shuiel, Raghad Adel Badoghaish, Saja Fawzi Alzanbaqi, Lamees Naji Alsaleh, Fatimah Essam Alzaid, Mustafa Abdulwahab AlShayeb, Fatimah Algawez, Rama K Alsulaim et al. · 2025 · Journal of Clinical Medicine
51. Atrial fibrillation post hematopoietic stem cell transplant: incidence, risk factors, and management challenges
    Hassan Kawtharany, Mohamad Ghazal, Abdallah Rayyan, Faizi A. Jamal · 2026 · Frontiers in Cardiovascular Medicine
52. Warfarin pharmacogenetics in patients with heart valve replacement
    Kıvanç Bezci, Mehtap Çevik, Cansu Selcan Akdeniz, İsmail Polat Canbolat, Selen Yurdakul, Murat Sünbül, Halil Atas, Penbe Çağatay, Çavlan Çiftçi, Atila Karaalp et al. · 2020 · Gene Reports
53. Major bleeding and thromboembolic complications associated with antithrombotic treatment in patients with atrial fibrillation/flutter and incident cancer
    Gordon K. T. Chu, Nienke van Rein, Menno V. Huisman, Lars Henning Pedersen, Henrik Toft Sørensen, Suzanne C. Cannegieter, Frederikus Albertus Klok · 2025 · Research and Practice in Thrombosis and Haemostasis
54. Efficacy and Safety of Drug and Device Strategies for Stroke Prevention in Atrial Fibrillation After Intracranial Hemorrhage: A Bayesian Network Meta-Analysis
    Fenglin Qi, Yuhang Yang, Lili Wang, Sixian Weng, Qinchao Wu, Yijie Liu, Zhipeng Hu, Liying Chen, Yunlong Wang · 2025 · Journal of Cardiovascular Development and Disease
55. Therapeutisches Management des nichtvalvulären Vorhofflimmerns
    Kerstin Bode, Philipp Sommer, Andreas Bollmann, Gerhard Hindricks · 2013 · Herz
56. Novel Oral Anticoagulants and Atrial Fibrillation: Efficacy and Safety Considerations
    Stavros Z. Apostolakis · 2013 · Drug Development Research
57. Recent advances in management of anti-coagulation in atrial fibrillation
    Puneet Anand, Prasun J. Mishra · 2015 · JOURNAL OF HEART AND CARDIOLOGY
58. Management des Vorhofflimmerns
    S. Hilbert, Kerstin Bode, Silke John, Simon Kircher, Andréas Müssigbrodt, Nikolaos Dagres, Gerhard Hindricks · 2014 · Der Kardiologe
59. Postmarketing Benefit-Risk Assessment for Erythropoiesis-Stimulating Agents Using a Health Care Database
    Yasuo Sugitani, Yukio Udagawa, Shinichi Matsuda, Kana Yamada, Natsuko Miyawaki, Ichiro Konishi · 2016 · Therapeutic Innovation & Regulatory Science
60. The Influence of Nonalcoholic Fatty Liver Disease on the Platelet Hemostasis and Endothelial Function State in Patients with Stable Coronary Heart Disease
    Iryna I. Vakalyuk, N. G. Virstyuk · 2018 · Ukraïnsʹkij žurnal medicini bìologìï ta sportu
61. Left Atrial Appendage Closure: A Safe and Effective Alternative to Anticoagulation?
    Margaret M. Infeld, Daniel N. Silverman, Daniel Lawrence Lustgarten · 2019 · Journal of Innovations in Cardiac Rhythm Management
62. Implantierbare EKG-Monitore
    Jilek, Clemens, Lewalter, Thorsten · 2020 · Herzschrittmachertherapie + Elektrophysiologie
63. The Year in Review of Clinical Cardiac Electrophysiology
    Gregory M. Marcus, Edmund C. Keung, Melvin M. Scheinman · 2013 · Journal of the American College of Cardiology
64. Management of patients with atrial fibrillation and minor bleeding during therapy with direct oral anti-coagulants
    Yu. N. Belenkov, L. V. Popova, S. I. Ilgisonis · 2021 · Kardiologiia
65. Atrial Fibrillation and Stroke
    Francesca Spagnolo, Vincenza Pinto, Augusto Maria Rini · 2022 · IntechOpen eBooks
66. Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation
    Anne Pernille Toft‐Petersen, Christina Ji‐Young Lee, Matthew David Phelps, Brice Ozenne, Thomas Alexander Gerds, Christian Tobias Torp-Pedersen · 2024 · PLoS ONE
67. Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry
    Max Jason, Lucas Marzec, Jonathan Paul Piccini, Peter J. Shrader, Karen S. Pieper, Rosalia G Blanco, Gregg C. Fonarow, Bernard John Gersh, P. Michael Ho, Elaine M. Hylek et al. · 2024 · International Journal of Cardiology
68. Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis
    Hagen B. Huttner, Felix Scherg, Katarina Kopke, Michael Schultze, Nils Kossack, Stefan T. Gerner, Joji B. Kuramatsu, Stefan Schwab · 2025 · Neurological Research and Practice
69. Target-specific oral anticoagulants and the hospitalist
    Steven Bruce Deitelzweig, Alpesh Amin · 2015 · Hospital Practice
70. Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study”
    Leif Friberg, Mårten Rosenqvist, Gregory Y.H. Lip · 2012 · Circulation
71. Contemporary Measures to Reduce the Risk of Embolic Events in Patients With Atrial Fibrillation
    Moutaz El Kadri, Ghaith Sharaf Dabbagh, Hakan Oral · 2015 · Future Cardiology
72. Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice
    N. M. Vorobyeva, O. N. Kacheva · 2018 · Rational Pharmacotherapy in Cardiology
73. Beneficios y riesgos de los anticoagulantes orales en la fibrilación auricular
    Vanessa Roldána, Francisco R. Marín · 2019 · Revista Española de Cardiología Suplementos
74. Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study
    Tommy Andersson, Sara Aspberg · 2020 · International Journal of Cardiology
75. An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants?
    Tatyana V. Pavlova · 2020 · Rational Pharmacotherapy in Cardiology
76. Identifying patients with atrial fibrillation with a single CHA2DS2-VASC risk factor who are at higher risk of stroke
    Yoav Arnson, Adi Berliner Senderey, Moshe Hoshen, Orna Reges, Ran D. Balicer, Hilmi Alnsasra, Morton Leibowitz, Meytal Avgil Tsadok, Moti Haim · 2021 · Irish Journal of Medical Science (1971 -)
77. Regarding the management of an elderly patient with atrial fibrillation
    О. М. Бiловол, І. І. Knyazkova · 2021 · Medicine of Ukraine
78. Atrial Fibrillation and Oral anticoagulation/Antiplatelet agents Practices in Low Middle-Income settings
    SAMWEL JACOB RWEYEMAMU, Reuben Mutagaywa, Naizihijwa Gadi Majani, Tatizo Waane, Peter Richard Kisenge · 2022 · European journal of applied sciences
79. Cardiovascular Evaluation and Treatment in the Endurance Athlete
    Andrew Hornick, Curt J. Daniels · 2023 · Springer eBooks
80. Personalised treatment with oral anticoagulant drugs : clinical and economic issues
    Talitha I. Verhoef · 2013 · Utrecht University Repository (Utrecht University)
81. Anticoagulant treatment is effective in atrial fibrillation
    John P Robson, Gregory Y.H. Lip · 2013 · BMJ
82. Letter by Spiegel et al Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study”
    Rainer Spiegel, Tobias Lorenz, Patrick Konietzny · 2012 · Circulation
83. Catch Atrial Fibrillation, Prevent Stroke : Detection of atrial fibrillation and other arrhythmias with short intermittent ECG
    Tijn Hendrikx · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
84. Prior bleeding, future bleeding and stroke risk with oral anticoagulation in atrial fibrillation: What new lessons can ARISTOTLE teach us?
    Shaun G. Goodman · 2016 · American Heart Journal
85. Benefit–Risk Assessments of Medical Treatments
    Bennett S. Levitan, Rachael L. DiSantostefano, Scott R. Evans · 2019 · Pharmacoepidemiology
86. Conundrums for Atrial Fibrillation Management in Older Adults
    Alexander C. Fanaroff, Tracy Y. Wang · 2015 · Current Geriatrics Reports
87. Study Of Genetic And Pharmacokinetic Issues Related To Efficacy And Toxicity Of Warfarin In Pakistani Subjec
    Aisha, Qayyum · 2014 · HEC National Digital Library
88. Fibrillation atriale non valvulaire : traitement antithrombotique conventionnel (antivitamines K et antiagrégants plaquettaires)
    Emmanuel Touzé · 2013 · Archives of Cardiovascular Diseases Supplements
89. Hémorragies cérébrales et nouveaux anticoagulants
    V. Derlon, G. Corbonnois, M. Martin, Marie Toussaint‐Hacquard, Gérard Audibert · 2014 · Annales Françaises d Anesthésie et de Réanimation
90. Sekundärprophylaxe des ischämischen Schlaganfalls
    Stefan Schwab, Lorenz Breuer · 2014 · Nervenheilkunde
91. Stroke and Bleeding Risks in Patients with Atrial Fibrillation
    Abhishek Maan, Jeremy Neil Ruskin, Edwin Kevin Heist · 2014 · Interventional Cardiology Clinics
92. Practical approaches to the treatment of atrial fibrillation: focus on stroke prevention using oral anticoagulant drugs
    Tatjana Potpara, Marina M. Licina, Marija M. Polovina · 2013 · Clinical Practice
93. The Calculated Risk of Defibrillator Implantation
    Gregory M. Marcus, Thomas A. Dewland · 2013 · Journal of the American College of Cardiology
94. Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
    Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro U · 2014 · Farmeconomia Health economics and therapeutic pathways
95. Comment évaluer le risque ischémique et hémorragique cérébral dans la fibrillation atriale ? Place des approches morphologiques et biologiques
    Ariel A. Cohen, Jean Yves Le Heuzey · 2014 · Archives of Cardiovascular Diseases Supplements
96. A New Era of Oral Anticoagulation in Atrial Fibrillation: Implications in Clinical Practice
    Charalampos Kasmeridis, Gregory Y.H. Lip, Stavros Z. Apostolakis · 2013 · Hospital Practice
97. How Can We Avoid a Stroke Crisis in Europe
    Felicita Andreotti, A. John Camm, Trudie Lobban · 2012
98. Neue Einsichten durch Real-World-Daten zu oralen Non-Vitamin-K-Antikoagulanzien
    Marek Jauß, Sibylle Kaiser, Christian Tanislav · 2016 · InFo Neurologie + Psychiatrie
99. Abstract 79: Reasons for Warfarin Discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
    Emily Claire O'Brien, DaJuanicia N. Holmes, Larry A. Allen, Daniel E. Singer, Gregg C. Fonarow, Peter Russell Kowey, Laine Elliott Thomas, Michael D. Ezekowitz, Kenneth W. Mahaffey, Paul Chang et al. · 2013 · Circulation Cardiovascular Quality and Outcomes
100. Anticoagulation for Atrial Fibrillation in the Emergency Department or Observation Unit
     Deepak L. Bhatt, Andrew E. Noll · 2016 · Contemporary cardiology